Monsuller, Eusebio .
HRN: 28-26-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/14/2025
12/20/2025
IV
145mg
Q8
Intestinal Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes